Juvéderm Voluma XC, also known simply as Voluma, stands out as a highly sought-after dermal filler within the extensive Juvéderm product range. Developed by the pioneering company Allergan, this hyaluronic acid-based filler swiftly gained approval from the Food and Drug Administration (FDA). Primarily intended for enhancing volume in the cheeks and midface, Juvéderm Voluma XC is FDA-approved for these specific applications. However, it is also widely used off-label to effectively treat areas such as the nose, temples, and chin. Discover the advantages of incorporating Juvéderm Voluma XC into your aesthetic practice today.
With mild side effects like temporary swelling, its effects can last up to 2 years. The cost of Juvederm Voluma XC typically ranges up to $1000 per syringe, with treatment expenses varying based on the unique needs of each client.
Juvéderm Voluma, often referred to simply as Voluma, is a durable and versatile hyaluronic acid-based gel filler from the renowned Juvéderm family. Developed by Allergan and approved by the FDA, Voluma is specifically designed to address volume loss in the cheeks and midface area due to aging. It stands out among Juvéderm products for its Vycross technology, which combines both low and high-molecular-weight hyaluronic acid to enhance longevity and reduce swelling post-treatment.
Initially FDA-approved for midface and cheek augmentation, Juvéderm Voluma has demonstrated effective off-label use in areas such as the nose, chin, temples, and even under the eyes. Studies have shown promising results, with high patient satisfaction rates in these off-label applications, particularly in enhancing facial contours and symmetry.
Like other dermal fillers, Juvéderm Voluma is injected into targeted areas to restore volume and improve facial contours. Its thick formulation allows for deep placement and effective lifting, resulting in a fuller, more youthful appearance. Immediate results are typically visible, with full benefits often realized within six months of treatment.
Clinical trials supporting its FDA approval have shown that nearly half of patients maintain noticeable improvements for up to two years after treatment. Satisfaction rates among patients are consistently high, with many reporting a significant reduction in the appearance of aging.
While generally considered safe, common side effects may include temporary swelling, redness, and tenderness at the injection site. These typically resolve within two weeks. Serious complications are rare but can include infections or allergic reactions. Patients over 50 and those receiving larger volumes may experience prolonged side effects, requiring additional management.
The cost of Juvéderm Voluma varies widely, typically ranging from $800 to $1,000 per syringe. Factors influencing cost include the amount of product required and the practitioner’s fees. Treatments targeting larger areas or requiring multiple syringes may incur higher costs. Despite its price, Juvéderm Voluma offers a cost-effective alternative to more invasive procedures, delivering long-lasting results and patient satisfaction.
Juvéderm Voluma remains a premier choice for enhancing facial volume and contouring, offering durable results and minimal downtime. While FDA-approved primarily for cheek augmentation, its versatile applications and high patient satisfaction make it a popular choice for comprehensive facial rejuvenation. Always consult with a qualified practitioner to determine if Juvéderm Voluma is suitable for your aesthetic goals and individual needs.
Join our newsletter to receive latest news and offers
Medicle MD Ltd
Reg. Number: 14317237
Address: 27 Old Gloucester Street,
WC1N 3AX London,
United Kingdom
